EndoStream Medical
Aneurysm Devices
Company Overview
Snapshot
Founded in October 2015 by Danel Mayer and Alon May, EndoStream Medical operates with 11–50 employees. The company was acquired by Kaneka Corporation in January 2025, marking a significant milestone in its journey.
Business overview
EndoStream Medical is a Health Tech & Life Sciences company focused on developing safe and effective solutions for patients with brain aneurysms. The company's core technology involves aneurysm devices that utilize self-conforming scaffolds, designed to adapt to an aneurysm’s unique shape and provide maximal neck metal coverage. Its flagship product, Nautilus, is an atraumatic, self-conforming intrasaccular flow diverter that maximizes neck coverage and enhances coil stability to optimize intrasaccular thrombosis and enable progressive occlusion. EndoStream Medical primarily serves the healthcare industry, specifically targeting surgeons and hospitals globally.
Strategic signal
EndoStream Medical was acquired by Japan's Kaneka Corporation in January 2025. This acquisition signals a strategic validation of EndoStream's aneurysm device technology and its potential to improve clinical outcomes for patients. For investors and innovation teams, this indicates a successful exit for the company and highlights the growing interest in advanced medical devices for neurovascular conditions within the Health Tech & Life Sciences sector.
Company Intelligence Q&A
- What is EndoStream Medical's primary focus?
- EndoStream Medical is dedicated to developing safe and effective solutions that significantly improve clinical outcomes for patients suffering from brain aneurysms, primarily through its advanced aneurysm devices.
- When was EndoStream Medical founded and by whom?
- EndoStream Medical was founded in October 2015 by Danel Mayer and Alon May.
- What is the Nautilus device?
- Nautilus is an atraumatic, self-conforming intrasaccular flow diverter developed by EndoStream Medical. It is designed to maximize neck coverage and enhance coil stability to optimize intrasaccular thrombosis and enable progressive occlusion for aneurysm treatment.
- When did EndoStream Medical enroll its first patient in the Nautilus trial?
- EndoStream Medical enrolled its first patient in the trial of the Nautilus Intrasaccular System in February 2023.
- When was EndoStream Medical acquired and by which company?
- EndoStream Medical was acquired by Kaneka Corporation in January 2025.